The Most Popular In‑Office Treatments of 2025, According to Real Readers

Aesthetic trends come and go, but NewBeauty readers remain some of the most discerning voices in the industry. To understand how they navigated 2025—from neurotoxins to next‑gen facials—we surveyed more than 400 readers* about their in‑office treatment choices. Their answers reveal a data-backed look at what mattered most last year and where their curiosity is headed in 2026.

Top Treatments of 2025

Despite economic uncertainty and rising treatment prices, readers continued to prioritize in‑office maintenance. These were the top three treatments booked in 2025.

- Advertisement -

Neurotoxins

Despite a crowded treatment landscape, neurotoxins remained the most-booked procedure of 2025, with 31 percent of respondents opting for wrinkle-relaxers like Botox Cosmetic, Dysport, Xeomin, Jeuveau and Daxxify.

High‑Tech Facials

High‑tech facials also had a strong year: nearly 21 percent of readers invested in device‑forward treatments like microcurrent, radio‑frequency or ultrasound-powered facials designed to deliver visible results without significant downtime.

Fillers, Laser Resurfacing/Light Therapy 

Fillers and laser resurfacing or light therapy were close behind, each chosen by 20.2 percent of respondents, underscoring the continued popularity of both injectable volume restoration and energy‑based skin rejuvenation.

Honorable Mentions

Other notable categories include chemical peels, which held steady at 16 percent, while medical‑grade facials accounted for 12 percent and teeth whitening for 9.5 percent. More niche or specialty treatments—such as skin tightening, which drew 7 percent, and IV therapy, selected by 5 percent—saw lighter but still notable traction. Exosome therapy, despite growing industry conversation, was booked by just 4 percent of respondents in 2025.

And interestingly, a full 38 percent of respondents reported skipping in‑office treatments entirely last year, suggesting many are either saving, researching or simply opting out of procedures for now.

What’s on the Horizon

Although exosome and regenerative treatments had low adoption in 2025, reader interest tells a different story. When asked about exosome therapy and other regenerative aesthetic options for the year ahead, the majority of readers expressed curiosity or active intent.

A combined 70 percent fell into the “very interested” or “somewhat interested” categories, with 155 respondents wanting to learn more and another 144 already exploring their options. Neutral respondents made up 20 percent, while only a small minority—roughly 10 percent total—said they had little to no interest in trying these treatments.

What It All Signals for 2026

If 2025 was about maintaining results with trusted treatments—neurotoxins, tech-forward facials, tried-and-true lasers—2026 is shaping up to be a year of exploration. Readers are clearly intrigued by regenerative aesthetics and willing to learn more, even if they haven’t taken the plunge yet.

*Source: BeautyEngine Advanced Research, 2026